<DOC>
	<DOCNO>NCT00134693</DOCNO>
	<brief_summary>This study design compare range dose SB-681323 prednisolone , know effect rheumatoid arthritis patient . By compare two drug effect blood protein indicate rheumatoid arthritis , hope ascertain information effective dose SB-681323 use future .</brief_summary>
	<brief_title>A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is Indicator For Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Inclusion criterion : Must diagnosis RA accord revised 1987 criterion American College Rheumatology . Must 3 swell 3 tender/painful joint screen . Must stable weekly methotrexate ( 2.5mg 25mg ) least eight week prior screen . Exclusion criterion : Must morbidly obese .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>SB-681323 rheumatoid arthritis CRP biomarkers</keyword>
</DOC>